RUBIN JONATHAN (SVP, Chief Medical Officer) received a stock award from SUPERNUS PHARMACEUTICALS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 2/26/2026ACC: 0001836067-26-000006
Officer· SVP, Chief Medical Officer
Since Jan 2021
-675.00
Net shares
Net seller
$34.2K
Total sold
0
Open market trades
0B · 0S
3
Total transactions
1.25K acquired · 1.93K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+1.25K
Price / share
—
Trade value
—
% of position
9.8%
2/25/2026
12.77K→14.02K
Common Stock
Direct
Shares
−675.00
Price / share
$50.69
Trade value
$34.22K
% of position
4.8%
2/25/2026
14.02K→13.34K
Total
Net shares
+575.00
Net value
-$34.22K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/25/2026 | A · Award | +1.25K | — | — | 9.8% | 12.77K | 14.02K |
| Common Stock Direct | 2/25/2026 | F · Tax Withholding | −675.00 | $50.69 | $34.22K | 4.8% | 14.02K | 13.34K |
| Total | +575.00 | -$34.22K | ||||||
Derivative Transactions1
Restricted Stock Unit
Direct
Converts to
Common Stock
1.25K shares
Shares
−1.25K
Strike price
Held after
1.25K
Exercisable
—
2/25/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Unit Direct | Common Stock1.25K shares | 2/25/2026 | D · Disposition | −1.25K | — | 1.25K |